ACOL - Acology, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.0104
-0.0003 (-2.80%)
At close: 3:42PM EDT
Stock chart is not supported by your current browser
Previous Close0.0107
Open0.0107
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0102 - 0.0112
52 Week Range0.0010 - 0.0250
Volume2,523,567
Avg. Volume3,939,017
Market Cap54.72M
Beta-5.47
PE Ratio (TTM)N/A
EPS (TTM)-0.0000
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • GlobeNewswire6 days ago

    Letter to Shareholders from ACOL CEO Curt Fairbrother: May 21, 2018

    Dear Shareholders: Many of you have been following our company since its inception in 2013 and have seen the steady growth that we have achieved in that time. A few of the remarkable achievements that Acology (ACOL) has attained in the first quarter of this year include equipment and infrastructure purchases in preparation of increased sales orders, the acquisition of the ENTIRE intellectual property portfolio for our signature product, the MedTainer™, the strengthening of our business relationships in Canada and the Canadian LPs, the expansion of business here in our native California and the expansion of our own, branded product lines that now account for almost 40% of our total sales. With these successes has come the certain knowledge that Acology is prepared to take full advantage of the continually escalating cannabis market worldwide.

  • GlobeNewswire12 days ago

    Acology 10Q Confirms Revenue and Net Income Surge: EU Patent Next

    Acology Inc. (ACOL-OTCMARKETS) released its’ 10Q, confirming that business continues to steadily grow and sustaining the expansion of the company that began more than 18 months ago. Acology continues to focus from the inside-out, accelerating plans implemented earlier this year to create a stronger core business and expand sharply into several aspects of the cannabis market, with an eye on becoming the preferred retail packaging unit for both the Canadian and US market. In addition, the steady increase in sales for Acology’s MedX 2-way humidity packs are accounting for the steady rise in the company’s net revenues.

  • GlobeNewswire27 days ago

    Acology Secures Canadian Patent for MedTainer™

    CORONA, Calif., April 30, 2018-- Acology Inc. announced today that their signature product, the MedTainer, has been granted a Utility Patent from the Canadian Intellectual Property Office.. The Canadian ...

  • GlobeNewswirelast month

    Acology Purchases Entire MedTainer Intellectual Property Portfolio

    CORONA, Calif., April 23, 2018-- Acology Inc. is pleased to announce the purchase of the entire intellectual property portfolio for their signature product, the MedTainer™. The purchase includes both the ...

  • GlobeNewswire2 months ago

    Acology 10K Highlights Accomplishments, Looks Confidently Forward

    CORONA, Calif., April 02, 2018-- Acology Inc. released its 2017 10 K report today, highlighted by steady growth and proportionately lowered operating expenses.. In terms of the bottom line, investors should ...

  • GlobeNewswire2 months ago

    Big Leap for LP MedTainer Orders; California Ramps Up

    CORONA, Calif., March 12, 2018-- Acology Inc. revealed today that Canadian licensed producers Aurora Cannabis Inc., OrganiGram and Tilray have posted March orders for more than 30,000 MedTainers, a sharp ...

  • Investopedialast year

    Pot Stock Winners of the Week

    Canadian-licensed producers surged this week.